Inhibition of NRP1 by a blocking antibody prevents tumor growth increased by VEGF-A in a mouse model, suppresses mammosphere formation by breast cancer stem-like cells, and impairs the invasion of glioblastoma [62,63,64]. The gene discussed is VEGFA; the disease is glioblastoma.